Date published: 2025-12-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

ARL13A Activators

The creation and study of ARL13A Activators would begin with a comprehensive structural assessment of the protein. Techniques such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy might be employed to elucidate the three-dimensional structure of ARL13A, particularly focusing on the GTP-binding domain. This domain is where GTPase activity occurs, and therefore, it would be the primary target for activation. Activators might be designed to bind to allosteric sites that can influence the conformation of the GTP-binding domain, thereby increasing the efficiency of GTP binding or hydrolysis. Alternatively, activators could interact directly with the active site to stabilize the transition state of the GTP hydrolysis reaction, enhancing the protein's natural activity.

Following the identification of potential activator molecules, a series of biochemical assays would be crucial to evaluate their impact on ARL13A activity. GTPase assays could be implemented to quantify the GTP hydrolysis rate in the presence of these compounds, providing a direct measure of activation. In parallel, binding studies could be performed to determine the affinity of these activators for ARL13A, which would involve techniques such as isothermal titration calorimetry or fluorescence-based thermal shift assays. These studies would facilitate an understanding of the interaction between ARL13A and the activators at a molecular level. Iterative chemical synthesis and structure-activity relationship (SAR) analysis would be employed to refine the activator molecules, optimizing their potency and selectivity for ARL13A. The use of such activators would advance the understanding of the biological function of ARL13A and contribute to the broader knowledge of the ARL family of GTPases and their roles in cellular physiology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

May increase cAMP levels, leading to activation of PKA which can phosphorylate and regulate GTPases.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

Activator of Protein Kinase C (PKC) which may phosphorylate and regulate GTPases.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Inhibits GSK-3β, potentially affecting Wnt signaling and GTPase function.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Influences gene expression and might modulate GTPase activity during cellular differentiation.

Manganese(II) chloride beads

7773-01-5sc-252989
sc-252989A
100 g
500 g
$19.00
$30.00
(0)

Required as a cofactor for many enzymes, could affect GTPase activation state.

Sodium nitroprusside dihydrate

13755-38-9sc-203395
sc-203395A
sc-203395B
1 g
5 g
100 g
$42.00
$83.00
$155.00
7
(1)

NO can modulate protein function and signaling pathways involving GTPases.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

Increases intracellular Ca2+, which can activate calmodulin and influence GTPases.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$38.00
$58.00
$102.00
$202.00
8
(1)

Hsp90 inhibitor, could affect client proteins including GTPases.

Lovastatin

75330-75-5sc-200850
sc-200850A
sc-200850B
5 mg
25 mg
100 mg
$28.00
$88.00
$332.00
12
(1)

Inhibits HMG-CoA reductase; could affect prenylation and therefore the localization and function of GTPases.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

Could prevent the degradation of GTPases, potentially increasing their activity.